Lipella Pharmaceuticals (LIPO) Insider Trading & Ownership $2.64 -0.31 (-10.51%) (As of 11/13/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Lipella Pharmaceuticals (NASDAQ:LIPO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.95%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$31,300.00Number OfInsiders Selling(Last 12 Months)0 Get LIPO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipella Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LIPO Insider Buying and Selling by Quarter Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Lipella Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/14/2024Jonathan H KaufmanInsiderBuy1,250$6.08$7,600.00 3/18/2024Jonathan H KaufmanInsiderBuy3,750$6.32$23,700.00 (Data available from 1/1/2013 forward) LIPO Insider Trading Activity - Frequently Asked Questions Who is on Lipella Pharmaceuticals's Insider Roster? The list of insiders at Lipella Pharmaceuticals includes Jonathan H Kaufman. Learn more on insiders at LIPO. What percentage of Lipella Pharmaceuticals stock is owned by insiders? 36.95% of Lipella Pharmaceuticals stock is owned by insiders. Learn more on LIPO's insider holdings. Which Lipella Pharmaceuticals insiders have been buying company stock? The following insider purchased LIPO shares in the last 24 months: Jonathan H Kaufman ($31,300.00). How much insider buying is happening at Lipella Pharmaceuticals? Insiders have purchased a total of 5,000 LIPO shares in the last 24 months for a total of $31,300.00 bought. Lipella Pharmaceuticals Key ExecutivesDr. Jonathan Kaufman M.B.A. (Age 57)Ph.D., Co-Founder, Chairman, CEO, President, Secretary & Treasurer Compensation: $204.13kDr. Michael B. Chancellor M.D. (Age 65)Co-Founder, Chief Medical Officer & Director Compensation: $195.83kMr. Douglas Johnston CPA (Age 39)Chief Financial Officer Compensation: $185kMs. Michele GruberDirector of OperationsKatie JohnstonController More Insider Trading Tools from MarketBeat Related Companies INDP Insider Buying EGRX Insider Buying KPRX Insider Buying CDT Insider Buying AYTU Insider Buying VINC Insider Buying NKGN Insider Buying BIOR Insider Buying GLTO Insider Buying MBIO Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Here’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock This page (NASDAQ:LIPO) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIPO Stock Alerts